Saturday 17 October 2026
Export IRMD’s income statement to Excel — free account
iRadimed Corporation
IRMD Healthcare Medical Devices
iRadimed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $83.8 million, up 14.4% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS fell 8.89% and free cash flow grew 11.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years.
88.27
1.10
−1.23%
Follow IRMD
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
16.47 | 306.00 | 41.46 | 27.19 | 190.00 | 61.61 | 27.92 | 34.77 | 35.95 | 54.96 |
Piotroski F-Score |
5 | 5 | 8 | 7 | 5 | 7 | 6 | 5 | 8 | 6 |
Altman Z-Score |
17.14 | 18.29 | 27.10 | 16.85 | 19.28 | 34.66 | 20.98 | 20.17 | 39.44 | 55.62 |
P/S ratio |
3.73 | 7.05 | 8.65 | 6.85 | 8.72 | 13.64 | 6.71 | 9.09 | 9.51 | 14.77 |
P/FCF ratio |
16.97 | 64.04 | 37.20 | 27.39 | 55.43 | 55.62 | 50.28 | 132.86 | 44.01 | 79.57 |
Altman Z″-Score (non-manufacturers) |
15.35 | 12.83 | 14.80 | 13.07 | 13.74 | 15.22 | 14.85 | 10.86 | 15.76 | 14.84 |
Beneish M-Score |
(1.37) | (2.77) | (2.46) | (1.50) | (3.19) | (2.57) | (1.02) | (2.28) | (2.71) | (2.55) |
P/Operating CF |
54.49 | 116.18 | 74.29 | 66.80 | 110.74 | 169.49 | 117.74 | 152.33 | 116.40 | 208.96 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 40 |
P/B ratio |
3.80 | 4.94 | 6.27 | 4.75 | 4.50 | 7.90 | 4.86 | 8.34 | 8.03 | 13.08 |
Price to Tangible BV |
3.91 | 5.08 | 6.40 | 4.83 | 4.57 | 8.03 | 5.00 | 8.65 | 8.32 | 13.57 |
EV/Sales |
2.94 | 5.91 | 7.52 | 5.65 | 7.08 | 12.15 | 5.63 | 8.33 | 8.80 | 14.16 |
EV/EBITDA |
8.04 | 52.60 | 32.18 | 21.99 | 385.25 | 45.26 | 18.40 | 26.26 | 28.29 | 43.44 |
EV/Operating CF |
10.15 | 39.94 | 31.02 | 21.26 | 38.58 | 45.12 | 29.86 | 40.57 | 25.16 | 47.56 |
EV/FCF |
13.38 | 53.67 | 32.34 | 22.59 | 45.01 | 49.53 | 42.14 | 121.76 | 40.71 | 76.28 |
Quick Ratio |
8.04 | 7.39 | 8.23 | 9.14 | 11.50 | 9.91 | 8.33 | 3.80 | 7.38 | 6.37 |
Current Ratio |
9.25 | 8.61 | 9.50 | 10.06 | 12.96 | 11.18 | 9.06 | 4.65 | 8.84 | 7.98 |
Net Debt/EBITDA |
(2.16) | (10.16) | (4.84) | (4.68) | (89.20) | (5.57) | (3.56) | (2.39) | (2.29) | (1.87) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.90 | 0.61 | 0.70 | 0.67 | 0.46 | 0.54 | 0.63 | 0.74 | 0.77 | 0.81 |
Operating CF/Net income |
1.30 | 6.83 | 1.17 | 1.06 | 4.25 | 1.21 | 0.78 | 0.78 | 1.33 | 1.11 |
Capex/Depreciation |
(1.59) | (0.63) | (0.24) | (0.39) | (0.48) | (0.53) | (2.80) | (10.46) | (10.78) | (7.22) |
| 22.61% | 1.54% | 16.84% | 19.76% | 2.34% | 13.96% | 17.59% | 23.70% | 24.31% | 24.78% | |
| 19.92% | 1.31% | 14.42% | 16.72% | 1.99% | 12.12% | 15.24% | 19.35% | 20.20% | 21.71% | |
ROIC |
109.91% | 12.19% | 49.58% | 58.28% | (5.02%) | 63.44% | 62.16% | 57.82% | 39.69% | 37.60% |
Return on Tangible Assets |
22.79% | 1.52% | 15.11% | 17.46% | 2.25% | 13.04% | 17.98% | 24.93% | 23.02% | 23.69% |
Average Days of Receivables |
42.41 | 59.76 | 50.48 | 69.11 | 52.65 | 44.84 | 90.90 | 68.06 | 52.61 | 59.52 |
Research and Development Expense of Revenue |
4.15% | 7.46% | 4.98% | 3.72% | 6.00% | 4.56% | 4.27% | 4.36% | 3.87% | 3.55% |
Selling, General and Administrative Expense of Revenue |
43.31% | 62.84% | 51.60% | 50.94% | 70.71% | 48.61% | 43.86% | 41.59% | 43.08% | 42.00% |
Intangible Assets out of Total Assets |
0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | 0.03 |
Share Based Compensation of Revenue |
5.67% | 10.63% | 5.80% | 4.82% | 12.49% | 3.49% | 2.62% | 3.34% | 3.45% | 3.48% |
Graham Net Nets |
0.24 | 0.18 | 0.14 | 0.18 | 0.20 | 0.11 | 0.18 | 0.09 | 0.09 | 0.05 |
Graham Number |
6.72 | 1.87 | 7.19 | 9.76 | 3.70 | 9.93 | 11.60 | 13.17 | 15.36 | 17.21 |
Earnings Yield |
6.07% | 0.33% | 2.41% | 3.68% | 0.53% | 1.62% | 3.58% | 2.88% | 2.78% | 1.82% |
Free Cash Flow Yield |
5.89% | 1.56% | 2.69% | 3.65% | 1.80% | 1.80% | 1.99% | 0.75% | 2.27% | 1.26% |
Revenue per Share |
3.00 | 2.17 | 2.83 | 3.41 | 2.62 | 3.39 | 4.24 | 5.20 | 5.78 | 6.59 |
Operating CF per Share |
0.87 | 0.32 | 0.69 | 0.91 | 0.48 | 0.91 | 0.80 | 1.07 | 2.02 | 1.96 |
Capex per Share |
(0.14) | (0.08) | (0.02) | (0.04) | (0.05) | (0.06) | (0.15) | (0.64) | (0.70) | (0.66) |
Free Cash Flow per Share |
0.73 | 0.24 | 0.66 | 0.86 | 0.43 | 0.85 | 0.65 | 0.43 | 1.33 | 1.30 |
Cash per Share |
2.37 | 2.48 | 3.20 | 4.10 | 4.29 | 5.06 | 4.61 | 3.95 | 4.12 | 4.02 |
Shareholders Equity per Share |
2.95 | 3.10 | 3.90 | 4.92 | 5.06 | 5.85 | 5.86 | 5.67 | 6.85 | 7.44 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
2.95 | 3.10 | 3.90 | 4.92 | 5.06 | 5.85 | 5.86 | 5.67 | 6.85 | 7.44 |
Free Cash Flow |
7.88 | 2.59 | 7.11 | 9.75 | 5.18 | 10.52 | 8.17 | 5.46 | 16.81 | 16.53 |
Working Capital |
30.19 | 31.03 | 39.85 | 53.10 | 58.82 | 69.42 | 68.94 | 59.67 | 66.73 | 71.02 |
Capital Expenditures |
(1.52) | (0.82) | (0.26) | (0.49) | (0.64) | (0.74) | (1.87) | (8.01) | (8.82) | (8.42) |
Net Current Asset Value |
28.55 | 29.03 | 38.05 | 47.76 | 54.05 | 65.54 | 65.65 | 55.27 | 63.74 | 67.05 |
EV/EBIT |
8.74 | 106.17 | 38.11 | 25.16 | 0.00 | 51.74 | 19.19 | 27.26 | 29.35 | 45.38 |
Capex to Sales |
0.05 | 0.04 | 0.01 | 0.01 | 0.02 | 0.02 | 0.04 | 0.12 | 0.12 | 0.10 |
Price to Operating Income |
11.10 | 126.66 | 43.83 | 30.50 | 0.00 | 58.11 | 22.89 | 29.75 | 31.73 | 47.33 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.66 | 0.70 | 0.59 | 0.60 | 0.63 | 0.68 | 0.28 | 0.08 | 0.05 | 0.05 |
Cash ROIC |
13.69% | 4.37% | 9.32% | 9.58% | 4.57% | 7.81% | 6.20% | 4.50% | 12.09% | 11.34% |
Accounts Receivable Turnover |
8.51 | 6.11 | 7.62 | 6.70 | 5.34 | 8.61 | 5.79 | 5.14 | 6.43 | 6.92 |
Accounts Payable Turnover |
5.79 | 6.27 | 10.09 | 9.98 | 9.87 | 13.56 | 9.31 | 8.43 | 9.00 | 10.49 |
Inventory Turnover |
1.96 | 1.38 | 1.74 | 2.29 | 2.15 | 2.37 | 2.49 | 1.69 | 1.45 | 1.77 |
Average Days of Payables |
66.47 | 43.03 | 39.10 | 41.14 | 29.45 | 29.26 | 54.63 | 44.00 | 40.97 | 34.08 |
Days of Inventory on Hand |
230.49 | 275.94 | 205.46 | 150.77 | 176.34 | 160.72 | 163.03 | 303.80 | 224.77 | 217.61 |
Average Receivables |
3.82 | 3.78 | 3.99 | 5.75 | 5.93 | 4.86 | 9.21 | 12.75 | 11.39 | 12.11 |
Average Payables |
1.06 | 0.89 | 0.71 | 0.88 | 0.83 | 0.72 | 1.29 | 1.83 | 1.88 | 1.86 |
Average Inventory |
3.13 | 4.05 | 4.14 | 3.85 | 3.79 | 4.12 | 4.83 | 9.10 | 11.61 | 11.01 |
Average Assets |
36.22 | 38.10 | 43.73 | 57.59 | 68.90 | 76.97 | 84.20 | 88.83 | 95.24 | 103.55 |
Average Common Equity |
31.91 | 32.41 | 37.44 | 48.74 | 58.45 | 66.78 | 72.92 | 72.55 | 79.12 | 90.72 |
Columns are period end dates